GlassScriptPhysician profile
Connie Chong
NPI 1184045643
$2,460.04
in general payments reported to CMS, 2019-2025
38 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $454 · 2022: $875 · 2023: $678 · 2024: $189 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $485.13 | 2022-2025 | Restrata Wound Matrix |
| Janssen Pharmaceuticals, INC | $267.76 | 2021-2022 | |
| Davol INC. | $217.81 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $174.04 | 2023-2025 | |
| Seagen INC. | $136.02 | 2021-2023 | Tukysa |
| Daiichi Sankyo INC. | $123.79 | 2021-2023 | Enhertu |
| Onkos Surgical, INC. | $84.34 | 2023 | Eleos Limb Salvage System |
| Stryker Corporation | $75.59 | 2024 | Motionsense Digital Goniometer |
| Integra Lifesciences Corporation | $69.53 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astrazeneca Pharmaceuticals LP | $67.23 | 2021-2023 | Imfinzi |
| Glaxosmithkline, LLC. | $65.27 | 2022-2023 | Shingrix |
| Amgen INC. | $63.95 | 2021-2023 | Xgeva, Vectibix, Nplate |
| Karyopharm Therapeutics INC. | $58.05 | 2022-2023 | Xpovio |
| Eisai INC. | $49.74 | 2023-2024 | |
| Abbvie INC. | $44.10 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Chong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.